Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers: Clinical and biological implications

American Journal of Pathology

Volumn 149, Issue 4, 1996, Pages 1167-1175

  Wu, Pui Chee ^a   Fang, Jane Wing Sang ^a,b   Lau, Victor Ka Tai ^b   Lai, Ching Lung ^a   Lo, Chi Kin ^a   Lau, Johnson Yiu Nam ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CYCLINE; CYTOKERATIN; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029794269     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hosono S, Chou MJ, Lee CS, Shih C: Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene 1993, 8:491-496
2. Debuire B, Paterlini P, Pontisso P, Basso G, May E: Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas. Oncogene 1993, 8:2303-2306
3. Volkmann M, Hofmann WJ, Muller M, Rath U, Otto G, Zentgraf H, Galle PR: p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene 1994, 9:195-204
4. Saegusa-M, Takano-Y, Kishimoto-H, Wakabayashi-G, Nohga-K, Okudaira-M: Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas: an enhanced immunohistochemical approach. J Cancer Res Clin Oncol 1993, 119:737-744
5. Mehmet Ozturk: p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991, 338:1356-1359
6. Bressac B, Kew M, Wands J, Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 1991, 350:429-431
7. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hot spot in the p53 gene in human hepatocellular carcinomas. Nature 1991, 350:427-428
8. Aterman K: The stem cells of the liver: a selective review. J Cancer Res Clin Oncol 1992, 118:87-115
9. Bennoun M, Rissel M, Engelhardt N, Guillouzo A, Briand P, Weber Benarous A: Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice. Am J Pathol 1993, 143:1326-1336
10. Dunsford HA, Karnasuta C, Hunt JM, Sell S: Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Res 1989, 49:4894-4900
11. Sell S: Distribution of α-fetoprotein and albumin-containing cells in the livers of Fischer rats fed four cycles of N-2-fluorenylacetamide. Cancer Res 1978, 38:3107-3113
12. Lau JYN, Wright T: Molecular virology and pathogenesis of hepatitis B. Lancet 1993, 342:1335-1340
13. Allen RA, Lisa JR: Combined liver cell and bile duct carcinoma. Am J Pathol 1994, 25:647-655
14. Shimoyama T, Shimizu T, Miyashita K, Kusano H, Jibiki M, Akamine S, Akama Y, Itoyanagi N, Nakamura A, Yasutake T: Study of combined hepatocellular and cholangiocarcinoma. Gan To Kagaku Ryoho 1993, 20: 295-298
15. Okuda K: The Liver Cancer Study Group of Japan: primary liver cancers in Japan. Cancer 1980, 45:2663-2669
16. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L: Combined hepatocellular-cholangiocellular carcinoma. Cancer 1985, 55:124-135
17. Ishak KG: Histological Typing of Tumors of the Liver. Geneva, World Health Organization, 1994
18. Edmondson HA, Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954, 7:462-503
19. Wennerberg AE, Nalesnik MA, Coleman WB: Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993, 143:1050-1054
20. Gibson JB, Wu PC, Ho JCI, Lauder IJ: Hepatitis B surface antigen, hepatocellular carcinoma, and cirrhosis in Hong Kong: a necropsy study: 1963-1976. Br J Cancer 1980, 42:370-277
21. Ho J, Wu PC, Kung TM: An autopsy study of hepatocellular carcinoma in Hong Kong. Pathology 1981, 13: 409-416
22. Lai CL, Lau JYN, WU PC, Hui WM, Lai ESC, Fan ST, Ngan H, Lin HJ: Subclinical hepatocellular carcinoma in Hong Kong Chinese. Oncology 1992, 49:347-353
23. Lai CL, Lam KC, Wong KP, Wu PC, Todd D: Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer 1981, 47:2746-2755
24. Wu PC, Lai CL, Lam KC, Lok ASF, Lin HJ: Clear cell carcinoma of liver: an ultrastructural study. Cancer 1983, 52:504-507
25. Sacho M, Setsu K, Hayashi K: Histochemical and immunohistochemical analyses of primary carcinoma of the liver. Acta Med Okayama 1991, 45:423-432
26. Hanabata M, Ohyanagi H, Saitoh Y, Itoh H: Immunohistochemical study on hepatic tumors: KM01 stains compared with AFP, CEA, CA19-9, and RAS P21. Kobe J Med Sci 1991, 37:81-96
27. Van Eyken P, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ: Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol 1988, 19:562-568
28. Roskams T, Willems M, Campos RV, Drucker DJ, Yap SH, Desmet VJ: Parathyroid hormone-related peptide expression in primary and metastatic liver tumors. Histopathology 1993, 23:519-525
29. Taniai M, Tomimatsu M, Okuda H, Saito A, Obata H: Immunohistochemical detection of proliferating cell nuclear antigen in hepatocellular carcinoma: relationship to histological grade. J Gastroenterol Hepatol 1993, 8:420-425
30. Sell S: The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma, Int J Dev Biol 1993, 37:189-201
31. Sell S, Dunsford HA: Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989, 134:1347-1363
32. Lau JYN, Lai CL: Hepatocarcinogenesis. Trop Gastroenterol 1990, 11:9-24
33. Aguilar F, Hussain SP, Cerutti P: Aflatoxin B1 induces the transversion of G to T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 1993, 90:8586-8590
34. Scorsone KA, Zhou YZ, Butel JS, Slagle BL: p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 1992, 52:1635-1638
35. Oren M, Maltzman W, Levine AJ: Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1981, 1:101-110
36. Reich NC, Oren M, Levine AJ: Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol 1983, 3:2143-2150
37. Rogel A, Popliker M, Webb CG, Oren M: p53 cellular tumor antigen: analysis of mRNA in normal adult tissue, embryos, and tumors. Mol Cell Biol 1985, 5:2851-2855
38. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 1991, 88:5006-5010
39. Hsia CC, Thorgeirsson SS, Tabor E: Expression of hepatitis B surface and core antigens and transforming growth factor-a in "oval cells" of the liver in patients with hepatocellular carcinoma. J Med Virol 1994, 43:216-221